Kurtoglu Metin 4
4 · Cartesian Therapeutics, Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Kurtoglu Metin
Chief Technology Officer
Transactions
- Sale
Common Stock
2025-01-03$16.72/sh−2,417$40,417→ 64,716 total - Sale
Common Stock
2025-01-06$16.83/sh−2,458$41,374→ 62,258 total
Footnotes (1)
- [F1]Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.